Source: Tilray, Inc.
  • Tilray (TLRY) has announced the launch of medical cannabis edibles
  • The new Tilray-branded medical cannabis edibles are now available for patients across Canada
  • Tilray’s new medical cannabis edibles include cannabis-infused chocolate bars and two formulations of medical cannabis soft chews
  • Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis
  • Tilray stock (TSX:TLRY) is down 0.33 per cent, trading at C$18.04 per share at 11:15 am ET

Tilray (TLRY) has announced the launch of medical cannabis edibles in THC and CBD-rich varieties of chocolates and soft chew gummies.

The new Tilray-branded medical cannabis edibles are now available for patients across Canada, adding to the brand’s comprehensive offering of cannabis medicines, including whole flower, oils, vapes, and pre-rolls developed with patient health and wellbeing in mind.

Irwin D. Simon, Tilray’s Chairman and Chief Executive Officer remarked on the product launch.

“Whether it’s pain management, anxiety treatment, or everything in between, patients are asking for more choices in the medical cannabis category, and Tilray remains committed to the innovations that improve patient wellbeing. As cannabis regulations evolve around the world, we look forward to offering our global patient community the highest-quality medicines they depend on for health, wellness and wellbeing.”

Tilray’s new medical cannabis edibles include two formulations of 16-gram medical cannabis-infused chocolate bars in THC Milk Chocolate containing 10mg of THC and <1mg of CBD per package and CBD Dark Chocolate containing 1mg of THC and 20mg of CBD per package, as well as two formulations of medical cannabis soft chews available in Watermelon containing 10mg of THC and Pineapple-Mango containing 10mg of THC and 10mg of CBD.

Jim Meiers, President at Tilray Canada, said,

“Tilray continues to deliver the benefits of cannabis safely and reliably in unique formats that suit patients’ needs. Our goal is to help provide patients access to the highest-quality medical cannabis products that can improve their quality of life, and also support them with best-in-class service and programs so they make the choices best suited to their needs.”

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis.

More From The Market Online

Avicanna launches 10% CBD (THC free) formula in Canada

Avicanna (TSX:AVCN) launches RHO Phyto Micro Drop 100, a 10 per cent CBD (THC free), proprietary oral formulation in Canada.

Organigram looks to raise capital as cannabis stocks surge

Organigram (TSX:OGI), one of Canada's first cannabis stocks, announces an overnight marketed public offering of units for up to C$25 million.

Tilray and 10 Barrel Brewing unveil ready-to-drink canned cocktails

Tilray Brands (TSX:TLRY) subsidiary 10 Barrel Brewing introduces its latest newest ready-to-drink canned cocktails.